Back
Middlefield Banc 10K Form
Buy
60
MBCN
Middlefield Banc
Last Price:
30.85
Seasonality Move:
3.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-14 | 10Q | MBCN/Middlefield Banc Quarterly |
2023-11-13 | 10Q | MBCN/Middlefield Banc Quarterly |
2023-08-14 | 10Q | MBCN/Middlefield Banc Quarterly |
2023-05-15 | 10Q | MBCN/Middlefield Banc Quarterly |
2022-11-14 | 10Q | MBCN/Middlefield Banc Quarterly |
2022-08-08 | 10Q | MBCN/Middlefield Banc Quarterly |
Receive MBCN News And Ratings
See the #1 stock for the next 7 days that we like better than MBCN
MBCN Financial Statistics
Sales & Book Value
Annual Sales: | $71.89M |
---|---|
Cash Flow: | $5.83M |
Price / Cash Flow: | 11.31 |
Annual Sales: | $26.11 |
Price / Book: | 1.18 |
Profitability
EPS (TTM): | 1.76000 |
---|---|
Net Income (TTM): | $14.21M |
Gross Margin: | $0 |
Return on Equity: | 6.95% |
Return on Assets: | 0.78% |
Middlefield Banc Earnings Forecast
Key Middlefield Banc Financial Ratios
- The Gross Profit Margin over the past 4 years for MBCN is 0.00%.
- The Selling, General & Administrative Expenses for MBCN have been equal to 37.35% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 65.42% of Operating Income.
- The Net Earning history of MBCN is 24.16% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 14 years.
Middlefield Banc Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Banks |
Sector: | Financials |
Current Symbol: | MBCN |
CUSIP: | 596304 |
Website: | middlefieldbank.bank |
Debt
Debt-to-Equity Ratio: | 0.56 |
---|---|
Current Ratio: | 2.3 |
Quick Ratio: | 2.19 |
Price-to-Earnings
Trailing P/E Ratio: | 14.43 |
---|---|
Forward P/E Ratio: | 16.97 |
MBCN Technical Analysis vs Fundamental Analysis
Buy
60
Middlefield Banc (MBCN)
is a Buy
Is Middlefield Banc a Buy or a Sell?
-
Middlefield Banc stock is rated a Buy
The current Middlefield Banc [MBCN] share price is $30.89. The Score for MBCN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.